IVIG enters the central nervous system during treatment of experimental autoimmune encephalomyelitis and is localised to inflammatory lesions

作者: Signe Humle Jorgensen , Nicolas Storm , Poul Erik Hyldgaard Jensen , Henning Laursen , Per Soelberg Sorensen

DOI: 10.1007/S00221-006-0752-8

关键词: Experimental autoimmune encephalomyelitisCentral nervous systemCentral nervous system diseaseExtravasationBlood–brain barrierMultiple sclerosisImmune systemImmunologyPathologyNervous systemMedicine

摘要: Intravenous immunoglobulin (IVIG) treatment reduces the relapse rate in relapsing–remitting multiple sclerosis (MS) and may interfere with MS pathology through its various anti-inflammatory immunomodulatory properties. It is presently unknown whether IVIG enters central nervous system (CNS) sufficient amounts to influence local immune response within brain spinal cord, or if effects are entirely due peripheral actions of IVIG. The purpose present study was evaluate radiolabeled 99mTc CNS during experimental autoimmune encephalomyelitis (EAE) susceptible rat strain Dark Agouti. After vivo administration 99mTc-IVIG we observed significantly increased accumulation cord from rats EAE. Accumulation not detectable tissue control animals. In samples minor increases organ binding were liver kidney Localisation visualised by autoradiography revealed significant only areas also affected perivascular inflammation leakage serum proteins. conclusion, results indicate that extravasation occurs when blood–brain barrier function compromised

参考文章(45)
U G Andersson, U Skansén-Saphir, L Björk, J P Andersson, Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology. ,vol. 79, pp. 211- 216 ,(1993)
Frédérique Bard, Catherine Cannon, Robin Barbour, Rae-Lyn Burke, Dora Games, Henry Grajeda, Teresa Guido, Kang Hu, Jiping Huang, Kelly Johnson-Wood, Karen Khan, Dora Kholodenko, Mike Lee, Ivan Lieberburg, Ruth Motter, Minh Nguyen, Ferdie Soriano, Nicki Vasquez, Kim Weiss, Brent Welch, Peter Seubert, Dale Schenk, Ted Yednock, Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Medicine. ,vol. 6, pp. 916- 919 ,(2000) , 10.1038/78682
W.J.G. Oyen, R.A.M.J. Claessens, E.T.M. Dams, A.B. Wymenga, F.H.M. Corstens, J.W.M. van der Meer, O.C. Boerman, Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: A clinical study The Journal of Nuclear Medicine. ,vol. 39, pp. 119- 124 ,(1998)
Orhan Aktas, Frauke Zipp, Regulation of self-reactive T cells by human immunoglobulins--implications for multiple sclerosis therapy. Current Pharmaceutical Design. ,vol. 9, pp. 245- 256 ,(2003) , 10.2174/1381612033392152
Naoto Aihara, Hirokazu Tanno, J. J. Hall, Lawrence H. Pitts, L. J. Noble, Immunocytochemical localization of immunoglobulins in the rat brain: Relationship to the blood-brain barrier The Journal of Comparative Neurology. ,vol. 342, pp. 481- 496 ,(1994) , 10.1002/CNE.903420402
James R. Tonra, Brita S. Reiseter, Roland Kolbeck, Kumiko Nagashima, Robbie Robertson, Bruce Keyt, Ronald M. Lindsay, Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis. The Journal of Comparative Neurology. ,vol. 430, pp. 131- 144 ,(2001) , 10.1002/1096-9861(20010129)430:1<131::AID-CNE1019>3.0.CO;2-K
Massimo Filippi, Maria A. Rocca, Elisabetta Pagani, Giuseppe Iannucci, Maria Pia Sormani, Franz Fazekas, Stefan Ropele, Otto R. Hommes, Giancarlo Comi, European Study on Intravenous Immunoglobulin in Multiple Sclerosis Archives of Neurology. ,vol. 61, pp. 1409- 1412 ,(2004) , 10.1001/ARCHNEUR.61.9.1409
Srinivas Kaveri, Nagendra Prasad, Tchavdar Vassilev, Vincent Hurez, Anastas Pashov, Sebastien Lacroix-Desmazes, Michel Kazatchkine, Modulation of autoimmune responses by intravenous immunoglobulin (IVIg) Multiple Sclerosis Journal. ,vol. 3, pp. 121- 128 ,(1997) , 10.1177/135245859700300211
M. Lewanska, M. Siger-Zajdel, K. Selmaj, No difference in efficacy of two different doses of intravenous immunoglobulins in MS: clinical and MRI assessment. European Journal of Neurology. ,vol. 9, pp. 565- 572 ,(2002) , 10.1046/J.1468-1331.2002.00500.X